Daily Archives: September 27, 2014

Merck Serono Awards EUR 1 Million to the Winners of the First Grant for Oncology Innovation

DARMSTADT, Germany, September 27, 2014 /PRNewswire/ — Global winners selected for their unique research projects that have the potential to advance research for the personalized treatment of solid tumors Winners…

Boehringer Ingelheim’s afatinib Achieves Primary Endpoint in Global Phase III Study in Recurrent/Metastatic Head and Neck Squamous Cell Cancer

INGELHEIM, Germany, Sept. 27, 2014 /PRNewswire/ — Results from the LUX-Head & Neck 1 study show afatinib* significantly delayed tumour growth versus chemotherapy in patients following failure of their previous…